Have a feature idea you'd love to see implemented?
Let us know!
TSVT 2seventy bio Inc
Price (delayed)
$3.16
Market cap
$163.02M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.83
Enterprise value
$350.48M
Highlights
TSVT's EPS has surged by 51% year-on-year and by 40% since the previous quarter
The net income has increased by 49% year-on-year and by 39% since the previous quarter
2seventy bio's gross profit has shrunk by 77% YoY but it has increased by 2.4% QoQ
2seventy bio's revenue has shrunk by 69% YoY but it has increased by 3.4% QoQ
The equity has declined by 26% year-on-year and by 2.9% since the previous quarter
2seventy bio's gross margin has decreased by 25% YoY
Key stats
What are the main financial stats of TSVT
Market
Valuations
Earnings
Shares outstanding
51.59M
Market cap
$163.02M
Enterprise value
$350.48M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.71
Price to sales (P/S)
3.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.68
Revenue
$45.62M
EBIT
-$94.55M
EBITDA
-$86.08M
Free cash flow
-$140.72M
Per share
Balance sheet
Liquidity
EPS
-$1.83
Free cash flow per share
-$2.69
Book value per share
$4.43
Revenue per share
$0.87
TBVPS
$9.52
Total assets
$503.85M
Total liabilities
$275.74M
Debt
$247.45M
Equity
$228.1M
Working capital
$174.38M
Debt to equity
1.08
Current ratio
4.95
Quick ratio
4.87
Net debt/EBITDA
-2.18
Margins
Efficiency
Dividend
EBITDA margin
-188.7%
Gross margin
65.7%
Net margin
-207.3%
Operating margin
-349.6%
Return on assets
-18%
Return on equity
-40.9%
Return on invested capital
-14.7%
Return on capital employed
-20.6%
Return on sales
-207.3%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
TSVT stock price
How has the 2seventy bio stock price performed over time
Intraday
1.61%
1 week
-19.39%
1 month
-36.42%
1 year
101.27%
YTD
-26%
QTD
-33.05%
Financial performance
How have 2seventy bio's revenue and profit performed over time
Revenue
$45.62M
Gross profit
$29.98M
Operating income
-$159.49M
Net income
-$94.55M
Gross margin
65.7%
Net margin
-207.3%
2seventy bio's operating margin has plunged by 149% YoY but it has increased by 31% from the previous quarter
2seventy bio's gross profit has shrunk by 77% YoY but it has increased by 2.4% QoQ
2seventy bio's revenue has shrunk by 69% YoY but it has increased by 3.4% QoQ
TSVT's net margin has shrunk by 64% YoY but it is up by 41% QoQ
Growth
What is 2seventy bio's growth rate over time
Valuation
What is 2seventy bio stock price valuation
P/E
N/A
P/B
0.71
P/S
3.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.68
TSVT's EPS has surged by 51% year-on-year and by 40% since the previous quarter
TSVT's P/B is 29% below its last 4 quarters average of 1.0
The equity has declined by 26% year-on-year and by 2.9% since the previous quarter
2seventy bio's revenue has shrunk by 69% YoY but it has increased by 3.4% QoQ
TSVT's P/S is 10% below its last 4 quarters average of 4.0
Efficiency
How efficient is 2seventy bio business performance
TSVT's return on sales has dropped by 64% year-on-year but it is up by 41% since the previous quarter
The ROIC has grown by 40% YoY and by 37% from the previous quarter
2seventy bio's ROA has increased by 36% from the previous quarter and by 33% YoY
The ROE has grown by 34% from the previous quarter and by 23% YoY
Dividends
What is TSVT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for TSVT.
Financial health
How did 2seventy bio financials performed over time
TSVT's total assets is 83% greater than its total liabilities
2seventy bio's quick ratio has increased by 23% YoY and by 4.5% from the previous quarter
TSVT's current ratio is up by 21% YoY and by 4% from the previous quarter
TSVT's debt is 8% higher than its equity
2seventy bio's debt to equity has increased by 27% YoY
The equity has declined by 26% year-on-year and by 2.9% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.